Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Shinobu, Waga"'
Publikováno v:
Clinical Nephrology. 64:258-263
Aim: It has been reported that the pharmacokinetics ofcyclosporin A (CsA) in children is different from that in adults. It appears that, in general, pediatric patients metabolize CsA more rapidly than adult patients, necessitating the use of higher d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd028365a954274d31b4ac088cfb7a37
https://doi.org/10.5414/cnp64258
https://doi.org/10.5414/cnp64258
Publikováno v:
Scopus-Elsevier
Aim: Mizoribine (MZR) is a newly developed immunosuppressive agent in Japan. To relieve disease flare of lupus ne- phritis, a prospective pilot study of oral MZR pulse therapy (a phase II trial) is conducted as an alternative therapy to dose up of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096f2e22070d3d6cf525b26f915f4872
https://doi.org/10.5414/cnp60390
https://doi.org/10.5414/cnp60390
Publikováno v:
Clinical and Experimental Nephrology. 6:0254-0257
Background. The occurrence of idiopathic (primary) membranous glomerulonephritis (MGN) is relatively uncommon in childhood. Although a proportion of children with idiopathic MGN may show isolated antinuclear antibody (ANA) positivity, its clinical im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68def9b59ff39da358db1dc51afab366
https://doi.org/10.1007/s101570200044
https://doi.org/10.1007/s101570200044
Autor:
Hiroshi Tanaka, Koichi Suzuki, Tohru Nakahata, Takashi Tateyama, Kazuhiko Sugimoto, Yoshiki Kakizaki, Shinobu Waga
Publikováno v:
Nihon Shoni Jinzobyo Gakkai Zasshi. 14:155-158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2924c6aac3053e15234c9c43cb23a8d
https://doi.org/10.3165/jjpn.14.155
https://doi.org/10.3165/jjpn.14.155
Autor:
Shinobu Waga, Nobuhiro Monma, Tohru Nakahata, Senjo Iwami, Tatsuo Ito, Norio Onodera, Etsuro Ito, Hiroshi Tanaka, Koichi Suzuki
Publikováno v:
The Tohoku Journal of Experimental Medicine. 194:71-74
Two Japanese sisters with persistent uveitis showed significant increased levels of urinary beta-2 microglobulin. A percutaneous renal biopsy performed in the younger sister revealed tubulointerstitial nephritis (TIN) with helper/inducer T cell infil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53dd6b68acfde119382966a8104e25ae
https://doi.org/10.1620/tjem.194.71
https://doi.org/10.1620/tjem.194.71
Publikováno v:
Nihon Shoni Jinzobyo Gakkai Zasshi. 13:95-102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f1dfe482283e6bb19f61da9e0699319
https://doi.org/10.3165/jjpn.13.95
https://doi.org/10.3165/jjpn.13.95
Publikováno v:
The Tohoku Journal of Experimental Medicine. 191:177-181
A 9-year-old boy was referred to our hospital because of significant hematuria and proteinuria associated with hypocomplementemia. Although he had had a 3-year history of asymptomatic persistent proteinuria detected by urine screening of school child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd19d4b7b63be3b6811d3ac15b350491
https://doi.org/10.1620/tjem.191.177
https://doi.org/10.1620/tjem.191.177
Publikováno v:
Nihon Shoni Jinzobyo Gakkai Zasshi. 12:33-37
小児科一般診療での微小変化型ネフローゼ症候群 (MCNS) に対する免疫抑制剤mizoribine (MZB)，ciclosporine (CsA) を用いた免疫抑制療法の現状を明らかにするために，当科で治療管理中のMCNS例で
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58a4861b8fafb89abf6ff411eea32fb7
https://doi.org/10.3165/jjpn.12.33
https://doi.org/10.3165/jjpn.12.33
Publikováno v:
The Tohoku Journal of Experimental Medicine. 187:273-278
Long-term azathioprine therapy as an alternative treatment to cyclophosphamide was done in 2 children with steroid-dependent minimal-change nephrotic syndrome (MCNS). They had already been treated with prednisolone, intravenous methyl-prednisolone pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::553d1238e4c58e4cd529f2feadffce4e
https://doi.org/10.1620/tjem.187.273
https://doi.org/10.1620/tjem.187.273
Publikováno v:
Clinical Nephrology. 68:198-200
Sir, – Mizoribine (MZR) is a novel selective inhibitor of inosine monophosphate dehydrogenase in the de novo pathway, whose mode of action is very similar to that of mycophenolate mofetil (MMF). We previously reported the efficacy and safety of a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e079925e400688312156dee5e08aa192
https://doi.org/10.5414/cnp68198
https://doi.org/10.5414/cnp68198